We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Praxis Precision Medicines
PRAX
$10.1B
| $659K | ﹤0.01% |
2,376
+438
| +23% | +$119K |
|
2427
Amerant Bancorp
AMTB
$1.13B
| $657K | ﹤0.01% |
26,540
+655
| +3% | +$15.5K |
|
|
ZEUS
2428
DELISTED
Olympic Steel
ZEUS
| $655K | ﹤0.01% |
26,882
-3,433
| -11% | -$94.8K |
|
|
HTB
2429
HomeTrust Bancshares
HTB
$848M
| $653K | ﹤0.01% |
23,338
+725
| +3% | +$19.9K |
|
|
NPTN
2430
DELISTED
NEOPHOTONICS CORP
NPTN
| $652K | ﹤0.01% |
74,862
+2,375
| +3% | +$21.7K |
|
2431
Mercer International
MERC
$39.8M
| $651K | ﹤0.01% |
56,135
-15,526
| -22% | -$180K |
|
2432
RCI Hospitality Holdings
RICK
$215M
| $649K | ﹤0.01% |
9,474
+290
| +3% | +$19K |
|
|
AD
2433
Array Digital Infrastructure
AD
$3.05B
| $649K | ﹤0.01% |
20,344
+725
| +4% | +$24.1K |
|
2434
SI-BONE Inc
SIBN
$834M
| $647K | ﹤0.01% |
30,216
+1,475
| +5% | +$37.3K |
|
2435
Oppenheimer Holdings
OPY
$1.2B
| $643K | ﹤0.01% |
14,191
+450
| +3% | +$20.2K |
|
2436
Powell Industries
POWL
$7.71B
| $635K | ﹤0.01% |
77,559
-9,096
| -10% | -$81.8K |
|
|
GTHX
2437
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $632K | ﹤0.01% |
47,060
+1,078
| +2% | +$17.6K |
|
2438
Bar Harbor Bankshares
BHB
$666M
| $627K | ﹤0.01% |
22,354
+700
| +3% | +$19.4K |
|
2439
Dyne Therapeutics
DYN
$4.9B
| $623K | ﹤0.01% |
38,390
+1,400
| +4% | +$24.8K |
|
2440
Vuzix
VUZI
$224M
| $623K | ﹤0.01% |
59,590
+2,621
| +5% | +$35.1K |
|
2441
Luxfer Holdings
LXFR
$458M
| $619K | ﹤0.01% |
31,545
| – | – |
|
|
RBNC
2442
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $619K | ﹤0.01% |
19,609
+525
| +3% | +$14.9K |
|
2443
Oportun Financial
OPRT
$372M
| $617K | ﹤0.01% |
24,632
+835
| +4% | +$19.2K |
|
|
KBAL
2444
DELISTED
Kimball International
KBAL
| $617K | ﹤0.01% |
55,089
-35,920
| -39% | -$441K |
|
|
SWI
2445
DELISTED
SolarWinds Corporation Common Stock
SWI
| $617K | ﹤0.01% |
36,854
-23,438
| -39% | -$434K |
|
2446
Clarus
CLAR
$143M
| $615K | ﹤0.01% |
24,011
+640
| +3% | +$17.7K |
|
2447
Lands' End
LE
$403M
| $612K | ﹤0.01% |
25,978
+667
| +3% | +$22.9K |
|
2448
NRC Health Common Stock
NRC
$450M
| $612K | ﹤0.01% |
14,502
+435
| +3% | +$21.9K |
|
2449
Napco Security Technologies
NSSC
$1.48B
| $611K | ﹤0.01% |
28,374
+1,296
| +5% | +$24.3K |
|
|
CMRX
2450
DELISTED
Chimerix, Inc.
CMRX
| $610K | ﹤0.01% |
98,529
+5,793
| +6% | +$39.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.